Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530894 · ClinicalTrials.gov registry record · NA
THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 1,057
- Enrollment target
NCT00530894: Completed NA study, sponsored by Edwards Lifesciences.
NCT00530894 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 1,057 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00530894, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,057 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of the device and delivery systems (transfemoral and transapical) in high risk, symptomatic patients with severe aortic stenosis.
Primary Outcome
Death from any cause.
Interventions
- DEVICE Edwards SAPIEN Transcatheter Heart Valve
- DEVICE Surgical Valve Replacement
- OTHER medical management and/or balloon aortic valvuloplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,057 participants |
| Start Date | 2007-04 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT00530894 record still lists
NCT00530894 is an interventional study that assigns participants to a tested intervention. Its 1,057 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 3 interventions - of which Edwards SAPIEN Transcatheter Heart Valve is the first listed.
NCT00530894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00530894 about?
NCT00530894 is a clinical study titled "THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial". The purpose of this study is to determine the safety and effectiveness of the device and delivery systems (transfemoral and transapical) in high risk, symptomatic patients with severe aortic stenosis.
What is the current status of trial NCT00530894?
This trial is currently completed. It is a NA study. The enrollment target is 1,057 participants. The study started on 2007-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT00530894?
The interventions under investigation include: Edwards SAPIEN Transcatheter Heart Valve (DEVICE), Surgical Valve Replacement (DEVICE), medical management and/or balloon aortic valvuloplasty (OTHER).
Who is sponsoring clinical trial NCT00530894?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00530894's enrollment target sits among peer trials
1,057 99th of 2000 higher than 1,902 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07018869 · 1,057 participants · Phase 3
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- NCT03588286 · 1,058 participants · NA
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
- NCT03242642 · 1,056 participants · NA
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- NCT04372108 · 1,056 participants
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia